Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2014
07/02/2014CN102131826B 人类分拣蛋白的晶体结构及其用于鉴定分拣蛋白的配体的用途 Crystal structure of human sorting purposes and for the identification of the protein ligand of sortilin
07/02/2014CN102127147B 表皮生长因子受体模拟表位肽及其应用 Epidermal growth factor receptor analog epitope peptide and its application
07/02/2014CN101942449B 提高植物非生物胁迫耐受性和/或生物量的方法及用该方法所产生的植物 Improving plant tolerance to abiotic stress and / or biomass of a method and plant produced by the method
07/02/2014CN101784564B B7-dc变体 Variant B7-dc
07/02/2014CN101687030B 用于生产基于酵母的疫苗的方法 Yeast-based vaccine production method for
07/02/2014CN101432296B 聚乙二醇化的突变的肉毒梭菌毒素 PEGylated mutated botulinum toxin
07/02/2014CN101080419B 利用血管生成素样4蛋白的组合物和方法 The composition and method of angiopoietin-like 4 protein
07/01/2014US8765928 Identification of isolated genomic nucleotide fragments from the p15 region of chromosome 11 encoding human tumor suppressing subtransferable candidate 4 (TSSC4) and variants thereof
07/01/2014US8765927 Identification of isolated genomic nucleotide fragments from the p15 region of chromosome 11 encoding human cluster of differentiation antigen 81 and variants thereof
07/01/2014US8765924 Modified erythropoietin
07/01/2014US8765915 Modified coagulation factor VIIa with extended half-life
07/01/2014US8765914 Interleukin-B30 proteins
07/01/2014US8765913 Human frizzled (FZD) receptor polypeptides and methods of use thereof for treating cancer and inhibiting growth of tumor cells
07/01/2014US8765912 Taste receptors of the T1R family from domestic dog
07/01/2014US8765910 Method for amidating polypeptides with basic amino acid C-terminals by means of specific endoproteases
07/01/2014US8765908 Compositions for improving bone mass
07/01/2014US8765688 Anti-dandruff compositions containing peptides
07/01/2014US8765686 Polypeptides for treating and/or limiting influenza infection
07/01/2014US8765682 Method for in vivo residue-specific DOPA incorporation into mussel adhesive proteins
07/01/2014US8765680 Method for administering omega-conopeptide
07/01/2014US8765677 Omega conotoxin peptides
07/01/2014US8765676 Calcium sensing receptor modulating compounds and pharmaceutical use thereof
07/01/2014US8765675 Use of calcitonin in osteoarthritis
07/01/2014US8765672 Method of modulating release of biomolecules having heparin-binding affinity
07/01/2014US8765670 GDF3 propeptides and related methods
07/01/2014US8765669 Glycosylated GLP-1 peptide
07/01/2014US8765668 Methods of synthesis of β-aminobutyryl substituted compounds
07/01/2014US8765666 Adenovirus dodecahedron particles for delivery of pharmaceutical agents
07/01/2014US8765665 Albumin-free factor VIII formulations
07/01/2014US8765662 NOGO receptor binding protein
07/01/2014US8765466 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
07/01/2014US8765461 HIV antisense proteins
07/01/2014US8765413 Cell cultivation process
07/01/2014US8765389 Genetic products which are differentially expressed in tumors and use thereof
07/01/2014US8765145 LSA-5 liver stage and blood stage antigen of Plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria
07/01/2014US8765139 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
07/01/2014US8765136 Influenza hemagglutinin and neuraminidase variants
07/01/2014US8765130 Antagonistic DR3 ligands
07/01/2014US8765115 Method of treatment of gastrointestinal disorders with IL-10
06/2014
06/26/2014WO2014100385A1 Chimeric antigen receptors
06/26/2014WO2014100302A1 On-column refolding and purifying of lipoproteins
06/26/2014WO2014100289A1 Transcriptional regulation for improved plant productivity
06/26/2014WO2014100137A1 Immunoassay standards and measurement of tau using intra-assay calibration standards
06/26/2014WO2014099997A1 Compositions and methods that utilize a peptide tag that binds to hyaluronan
06/26/2014WO2014099850A1 FACTOR IXa 318R/A MUTANT
06/26/2014WO2014099669A1 Porcine parvovirus 5a, methods of use and vaccine
06/26/2014WO2014099577A1 Process for purifying insulin and analogues thereof
06/26/2014WO2014099134A1 Milk-based nutritional compositions containing lactoferrin and uses thereof
06/26/2014WO2014098939A1 Expression of xylose isomerase activity in yeast
06/26/2014WO2014098649A1 Compositions and methods using toll-like receptor 5 and toll-like receptor agonist
06/26/2014WO2014098468A1 Crystal structure of denatured eprs protein, and crystallization method therefor
06/26/2014WO2014098464A1 Human serum albumin heat-stabilizing composition, and production method for heat-stabilized human serum albumin using same
06/26/2014WO2014098188A1 METHOD FOR PRODUCING cis-5-HYDROXY-2-PIPERIDINECARBOXYLIC ACID DERIVATIVE, AND METHOD FOR PURIFYING cis-5-HYDROXY-2-PIPERIDINECARBOXYLIC ACID
06/26/2014WO2014098112A1 Modified lectin derived from wisteria floribunda
06/26/2014WO2014098089A1 Method for promoting fungi growth
06/26/2014WO2014098088A1 Antifungal agent
06/26/2014WO2014097932A1 Marker peptide for determining risk for hyperglycemia and use thereof
06/26/2014WO2014097323A1 Novel fusion tags and expression vector system for the expression of human parathyroid hormone (rhpth)
06/26/2014WO2014097126A1 Chemerin peptides, pharmaceutical composition comprising these peptides and use thereof
06/26/2014WO2014097123A1 Composition for topical use comprising lactoferrin.
06/26/2014WO2014097116A1 Stabilized insulin-like growth factor polypeptides
06/26/2014WO2014097113A2 Production of therapeutic proteins in genetically modified mammalian cells
06/26/2014WO2014096855A1 Angiopoietin-2 specific tie2 receptor
06/26/2014WO2014096803A1 Method for predicting the off-target biding of a peptide which binds to a target peptide presented by a major histocompatibility complex
06/26/2014WO2014096402A1 Enzyme having a nmda receptor antagonist activity and/or an anticholinergic activity
06/26/2014WO2014096367A1 Expression of beta2-microglobulin as a prognostic marker for tumour immune escape and resistance to cancer immunotherapy and a diagnostic biomarker for patient selection for specific gene therapy
06/26/2014WO2014096179A1 Novel glp-1 receptor agonists with cholesterol efflux activity
06/26/2014WO2014096163A1 New polypeptides
06/26/2014WO2014096150A1 Dual glp1/gip or trigonal glp1/gip/glucagon agonists
06/26/2014WO2014096149A1 Exendin-4 Derivatives
06/26/2014WO2014096148A1 Functionalized exendin-4 derivatives
06/26/2014WO2014096145A1 Exendin-4 derivatives as dual glp1/gip or trigonal glp1/gip/glucagon agonists
06/26/2014WO2014096015A1 Disulfide-linked multivalent mhc class i comprising multi-function proteins
06/26/2014WO2014096013A1 Novel recombinant outer membrane proteins from brachyspira hyodysenteriae and uses thereof
06/26/2014WO2014095998A1 A method for preventing or treating an hiv infection
06/26/2014WO2014095977A1 Novel pellino peptide
06/26/2014WO2014094799A1 Ubiquitin moieties as a means for prolonging serum half-life
06/26/2014WO2014094618A1 Polypeptides having endoglucanase activity and polynucleotides encoding same
06/26/2014WO2014094579A1 Recombinant protein
06/26/2014WO2014094406A1 Chromatographic method for isolating and purifying high-purity recombined human serum albumin
06/26/2014WO2014094292A1 Cotton zeaxanthin epoxidase zep-1 and coding gene and use thereof
06/26/2014WO2014094138A1 Screening methods to identify compounds inhibiting the activity of e2 enzymes by stabilization of non-covalent ubiquitin-e2 complexes and pharmaceutical applications related to e2 inhibitors
06/26/2014WO2014094122A1 Treatment of cd47+ disease cells with sirp alpha-fc fusions
06/26/2014WO2014094073A1 Gaba responsive motif
06/26/2014WO2014071397A3 Genetically modified non-human animals and methods of use thereof
06/26/2014WO2014058289A3 Method for obtaiining preparations of polypeptides having phytase activity and use thereof
06/26/2014WO2014055477A3 Genes controlling photoperiod sensitivity in maize and sorghum and uses thereof
06/26/2014WO2014018601A3 New modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins
06/26/2014WO2013103816A8 Partial mhc constructs and methods of use
06/26/2014WO2013082563A8 Protein inhibitors to complement and vegf pathways and methods of use thereof
06/26/2014WO2012162628A3 Lipopeptide inhibitors of ras oncoproteins
06/26/2014US20140182017 Molecular markers of plant embryogenesis
06/26/2014US20140182014 Isolated eIF-5A and Polynucleotides Encoding Same
06/26/2014US20140182013 Key gene regulating cell wall biosynthesis and recalcitrance in populus, gene y
06/26/2014US20140179899 Double-acylated glp-1 derivatives
06/26/2014US20140179898 Mutated protein of protein a having reduced affinity in acidic region and antibody-capturing agent
06/26/2014US20140179896 Inhibitors of type 2 vascular endothelial growth factor receptors
06/26/2014US20140179617 Cytotoxic Factors For Modulating Cell Death
06/26/2014US20140179612 Transferrin-Tumstatin Fusion Protein and Methods For Producing and Using the Same
06/26/2014US20140179611 Tribonectins
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 2916